These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9060650)

  • 1. Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model.
    Kreil TR; Eibl MM
    J Virol; 1997 Apr; 71(4):2921-7. PubMed ID: 9060650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.
    VanBlargan LA; Errico JM; Kafai NM; Burgomaster KE; Jethva PN; Broeckel RM; Meade-White K; Nelson CA; Himansu S; Wang D; Handley SA; Gross ML; Best SM; Pierson TC; Fremont DH; Diamond MS
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33831142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model.
    Kreil TR; Burger I; Attakpah E; Olas K; Eibl MM
    Vaccine; 1998; 16(9-10):955-9. PubMed ID: 9682343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.
    Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J
    J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
    Kreil TR; Maier E; Fraiss S; Eibl MM
    J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization.
    Chiba N; Osada M; Komoro K; Mizutani T; Kariwa H; Takashima I
    Vaccine; 1999 Mar; 17(11-12):1532-9. PubMed ID: 10195790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
    Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
    Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
    Morozova OV; Maksimova TG; Bakhvalova VN
    Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
    Matveev AL; Kozlova IV; Stronin OV; Khlusevich YA; Doroshchenko EK; Baykov IK; Lisak OV; Emelyanova LA; Suntsova OV; Matveeva VA; Savinova JS; Tikunova NV
    PLoS One; 2019; 14(4):e0215075. PubMed ID: 30958863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficiency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)].
    Pen'evskaia NA; Rudakov NV
    Med Parazitol (Mosk); 2010; (1):53-9. PubMed ID: 20361640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.